VRNA logo

VRNA Verona Pharma Plc American Depositary

About VRNA

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.
61

Bullish Sentiment

How do you feel about VRNA?

Advertisement|Remove ads.